Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Taxes: 2009-2020

Historic Change in Taxes for China Pharma Holdings (CPHI) over the last 12 years, with Sep 2020 value amounting to -$155,827.

  • China Pharma Holdings' Change in Taxes fell 332.74% to -$155,827 in Q3 2020 from the same period last year, while for Sep 2020 it was $113,571, marking a year-over-year increase of 1315.18%. This contributed to the annual value of $12,971 for FY2019, which is 108.82% up from last year.
  • China Pharma Holdings' Change in Taxes amounted to -$155,827 in Q3 2020, which was down 168.57% from $227,245 recorded in Q2 2020.
  • China Pharma Holdings' 5-year Change in Taxes high stood at $227,245 for Q2 2020, and its period low was -$163,335 during Q1 2018.
  • Its 3-year average for Change in Taxes is -$927.91, with a median of -$10,350 in 2019.
  • Its Change in Taxes has fluctuated over the past 5 years, first plummeted by 711.18% in 2017, then soared by 2,655.49% in 2020.
  • China Pharma Holdings' Change in Taxes (Quarterly) stood at $146,187 in 2016, then crashed by 88.35% to $17,034 in 2017, then tumbled by 291.78% to -$32,667 in 2018, then spiked by 68.32% to -$10,350 in 2019, then plummeted by 332.74% to -$155,827 in 2020.
  • Its Change in Taxes was -$155,827 in Q3 2020, compared to $227,245 in Q2 2020 and $52,503 in Q1 2020.